Gallardo, Efren A.

HRN: 01-50-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/13/2026
06/20/2026
IV
2.25g
Q8h
Infected DM Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines